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ABSTRACT
Intrauterine growth retardation (IUGR) is a common obstetric complication 
lacking an optimal method for prenatal screening. DNA methylation profile in maternal 
blood holds significant promise for prenatal screening. Here, we aimed to screen out 
potential IUGR biomarkers in maternal blood from the perspective of DNA methylation. 
The IUGR rat model was established by prenatal maternal undernutrition. High-
throughput bisulfite sequencing of genomic DNA methylation followed by functional 
clustering analysis for differentially methylated region (DMR)-associated genes 
demonstrated that genes regulating transcription had the most significantly changed 
DNA methylation status in maternal blood with IUGR. Genes about apoptosis and 
placental development were also changed. Besides increased placental apoptosis, 
IUGR rats demonstrated the same hypermethylated CpG sites of steroidogenic factor-1 
(SF-1, a DMR-associated transcription factor about placenta) promoter in maternal 
blood and placentae. Further, ff1b, the SF-1 ortholog, was knocked out in zebrafish 
by CRISPR/Cas9 technology. The knock-out zebrafish demonstrated developmental 
inhibition and increased IUGR rates, which confirmed the role of SF-1 in IUGR 
development. Finally, hypermethylated SF-1 was observed in human maternal blood 
of IUGR. This study firstly presented distinct DNA methylation profile in maternal 
blood of IUGR and showed hypermethylated SF-1 could be a potential IUGR biomarker 
in maternal rat blood.
INTRODUCTION
Intrauterine growth retardation (IUGR), which 
refers to the poor fetal growth in uterus, is a common 
obstetric complication [1]. IUGR not only induces 
perinatal morbidity and mortality, but also increases the 
susceptibility to some age-related diseases in the offspring, 
such as hypertension and type II diabetes [2–4]. Owing to 
the lack of effective intrauterine treatments, the current 
goal of IUGR management is early detection and timely 
delivery [5, 6]. Multiple methods have been combined for 
IUGR prediction, including biophysical profile, routine 
ultrasound, and molecular biological technique [7]. But 
there still lacks a definitively optimal method for screening 
IUGR during gestation.
The etiology of IUGR is largely attributed to adverse 
intrauterine environment during pregnancy. Epigenetics 
explains the relationship between gene expression and 
environmental signals. As a major mechanism of epigenetic 
modification, DNA methylation can affect the stable 
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maintenance of gene expression patterns [8, 9]. Meanwhile, 
DNA methylation is more sensitive to environmental stimuli 
than DNA sequences and more stable than RNA in maternal 
blood [8, 10]. Maternal blood provides gas and nutrients 
for the developing fetus and could provide an avenue of 
signal exchange [7]. DNA methylation analysis in maternal 
blood has been considered as a non-invasive method with 
advantages of good accuracy and sensitivity. It has been 
reported that DNA methylation patterns in maternal blood 
could be used for non-invasive prenatal diagnosis of trisomy 
21 and congenital heart defects [11, 12]. As to prenatal 
IUGR screening, hypermethylated RASSF1A in maternal 
blood was reported to be a possible IUGR biomarker [13]. It 
remains unclear whether genomic DNA methylation profile 
was generally changed in maternal blood of IUGR. And 
more evidence is needed to verify the role of aberrant DNA 
dysfunction in IUGR.
The placenta serves as an essential barrier for 
fetal development. Placental dysfunction-induced 
adverse intrauterine environment is taken as one of 
the predominant causes of IUGR [6, 14, 15]. And the 
underlying mechanism may be associated with the 
aberrant epigenetic modification in the placenta [16, 
17]. steroidogenic factor-1 (SF-1)  is an IUGR-related 
transcription factor crucial for placental development and 
syncytiotrophoblast apoptosis, of which the expression 
is associated with its promoter methylation status [18–
21]. As apoptotic syncytiotrophoblast cells flow into 
the maternal blood, placental DNA can be determined 
in the maternal blood [22, 23]. Thus, the aberrant DNA 
methylation of genes in IUGR placenta (such as SF-1) and 
the subsequent placental dysfunction may be reflected by 
the DNA methylation patterns in maternal blood.
In this study, we aimed to demonstrate DNA 
methylation profile in maternal blood of IUGR and to 
screen out potential IUGR biomarkers. The IUGR rat 
model was established by maternal undernutrition during 
pregnancy. And we used high-throughput sequencing of 
genomic DNA methylation to screen out changed DNA 
status of genes related to fetal and placental development 
in maternal blood. The screen-out gene was knocked out 
in zebrafish to verify its role in inducing IUGR. Further, 
the DNA methylation pattern of the screen-out gene 
was confirmed in peripheral blood of clinical pregnant 
women with IUGR. This study will provide evidence 
for understanding IUGR pathophysiology and the non-
invasive prenatal prediction of IUGR.
RESULTS
Developmental parameters in rats
In this study, an IUGR rat model was established 
successfully through prenatal maternal undernutrition. As 
shown in Figure 1A, maternal body weights of the control 
gained gradually during gestation. However, maternal 
body weights in the undernutrition group decreased 
during gestation and were significantly lower than that of 
the control since gestational day (GD) 3. On GD14, fetal 
body weights and placental weights in the undernutrition 
group were reduced to 75.0% and 68.8%, respectively, of 
the control (P<0.01, Figure 1B). And the ratio of placental 
weight to fetal weight in the undernutrition group was 
significantly lower than that in the control (P<0.01, Figure 
1C). IUGR rate in the undernutrition group increased to 
82.5%, which was 44 times higher than that in the control 
(P<0.01, Figure 1C).
Genomic DNA methylation sequencing in 
maternal rat blood
High-throughput genomic DNA methylation 
sequencing was employed to demonstrate DNA methylation 
profile in maternal rat blood. The majority of differentially 
methylated regions (DMRs) were distributed within 
intergenic regions, including promoters. The functional 
clustering analysis for top 3000 DMR-associated genes 
demonstrated that the most significantly changed DNA 
methylation patterns were in genes regulating transcription 
(Table 1). Placenta-related transcription factors of this 
cluster were shown in Table 2. Among the functional 
clusters related to fetal and placental development, 
Figure 1: Developmental parameters of rats under prenatal maternal undernutrition. The pregnant rats were fed a restricted 
diet (50% of the daily food intake of the control rats) from gestational day (GD) 0 to GD14. On GD14, the rats were anesthetized with 
isoflurane and sacrificed. (A) Maternal body weights; (B) fetal weights and placental weights; (C) intrauterine growth retardation (IUGR) 
rates and the ratio of placental weight to fetal weight and. Mean ± SD, *P<0.05, **P<0.01, two-sided t-test, n = 6 control vs. 5 undernutrition 
pregnant rats.
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remarkable changes were observed in apoptosis, cardiac 
development, neurodevelopment and placental development 
(Table 1). The specific genes involved in these functional 
clusters were shown in Table 2.
Table 1: Functional clusters for DMR associated genes
GO term Count P value FDR
Transcription regulation Enrichment score: 3.46
GO:0030528~transcription regulator activity 174 0.001 2.04
GO:0003677~DNA binding 238 0.009 13.46
GO:0006350~transcription 234 0.020 30.88
GO:0003700~transcription factor activity 108 0.030 38.42
GO:0045449~regulation of transcription 285 0.039 52.03
Apoptosis Enrichment Score: 2.30
GO:0008219~cell death 80 0.004 7.12
GO:0016265~death 81 0.005 8.88
GO:0006915~apoptosis 73 0.007 11.79
GO:0012501~programmed cell death 73 0.010 17.05
Cardiac development Enrichment Score: 1.48
GO:0060415~muscle tissue morphogenesis 8 0.003 5.11
GO:0055008~cardiac muscle tissue 
morphogenesis 8 0.003 5.11
GO:0003007~heart morphogenesis 18 0.004 7.59
GO:0055010~ventricular cardiac muscle 
morphogenesis 7 0.005 8.58
GO:0048738~cardiac muscle tissue 
development 14 0.012 20.53
Neurodevelopment Enrichment Score: 1.40
GO:0030030~cell projection organization 53 0.007 12.78
GO:0000904~cell morphogenesis involved in 
differentiation 37 0.013 20.93
GO:0032989~cellular component 
morphogenesis 54 0.028 40.93
GO:0048666~neuron development 46 0.030 42.73
GO:0048667~cell morphogenesis involved in 
neuron differentiation 31 0.031 43.92
GO:0030182~neuron differentiation 60 0.031 44.41
GO:0048812~neuron projection morphogenesis 30 0.034 46.66
GO:0007409~axonogenesis 28 0.037 50.05
Placental development Enrichment Score: 0.86
GO:0060716~labyrinthine layer blood vessel 
development 5 0.031 74.02
GO:0001890~placenta development 15 0.041 92.43
DMR, differentially methylated region; FDR, false discovery rate.
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DNA methylation status of SF-1 promoter in 
maternal rat blood
Among the 4 differentially methylated transcription 
factor, SF-1 has been proven as an IUGR-related 
gene in our previous studies [20]. Meanwhile, SF-1 
plays an important role in placental development and 
syncytiotrophoblast apoptosis, another two changed 
functional clusters [18, 19, 21]. Thus, hypermethylated 
SF-1 was selected for further investigation. It is widely 
accepted that hypermethylated gene promoter could induce 
inhibited gene expression via disturbing the binding with 
transcription factors [10, 24]. Thus, the methylation 
status of CpG sites in the -280/+60 domain of rat SF-1, 
which covers the binding sites for transcription factors, 
was verified in maternal blood. Figure 2A demonstrated 
the methylation map of CpG sites. As shown in Figure 
2B, the total methylation rate in the undernutrition group 
was significantly higher than that in the control (P<0.05). 
Among the 36 CpG sites, nt -235, -162, -14, -10 and -7 
showed increased frequency of single CpG methylation 
after undernutrition treatment (P<0.05, Figure 2C).
Placental histology and apoptosis in rats
Increased placental apoptosis was reported to induce 
aberrant placental development and IUGR [25, 26]. 
Thus, we analyzed the histology and cell apoptosis in rat 
Table 2: Genes involved in functional clusters for DMR associated genes
Gene symbol DMR_ID Description Methylation status Fold change
Genes about transcription regulation
Cdx2 Chr12_dmr_912 caudal type homeo box 2 hypermethylated 2.99
Cry2 Chr3_dmr_9973 cryptochrome circadian clock 2 hypermethylated 2.67
Rara Chr10_dmr_13437 retinoic acid receptor alpha hypermethylated 3.12
SF-1 Chr3_dmr_2513 steroidogenic factor-1 hypermethylated 3.67
Genes about apoptosis
Steap3 Chr13_dmr_2602
STEAP family 
member 3, 
metalloreductase
hypomethylated -2.01
Nfkb1 Chr2_dmr_26888
nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 1
hypomethylated -2.56
Inha Chr9_dmr_10674 inhibin alpha hypomethylated -3.09
Genes about cardiac development
Tbx1 Chr11_dmr_11267 T-box 1 hypermethylated 3.21
Foxc2 Chr19_dmr_7361 forkhead box C2 hypermethylated 2.42
Pitx2 Chr2_dmr_26037 paired-like homeodomain 2 hypermethylated 2.54
Genes about neurodevelopment
Cdk5 Chr4_dmr_868 cyclin-dependent kinase 5 hypomethylated 3.42
Lhx4 Chr13_dmr_7436 LIM homeobox 4 hypermethylated 2.89
Genes about placental development
Ncoa6 Chr3_dmr_19379 nuclear receptor coactivator 6 hypermethylated 2.78
Ovol2 Chr3_dmr_17597 ovo-like zinc finger 2 hypermethylated 3.21
DMR, differentially methylated region.
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placentae. As compared to the control (Figure 3A), fewer 
syncytiotrophoblasts and more dilated intercellular spaces 
were shown in the IUGR placentae stained with hematoxylin 
and eosin (HE) (Figure 3B). In addition, TdT-mediated dUTP 
nick end labelling (TUNEL) staining showed increased 
apoptosis in syncytiotrophoblasts of IUGR placentae (Figure 
3D) than that of the control (Figure 3C). The data from the 
semi-quantitative assay also demonstrated a statistically 
significant difference between the two groups (P<0.01, 
Figure 3G). The same phenomenon was also observed by 
transmission electron microscope (TEM) analysis, which 
exhibited typical apoptotic morphological changes in 
placental syncytiotrophoblasts of the IUGR group (Figure 
3F) but not in the control (Figure 3E). Specifically, these 
shrunken syncytiotrophoblast cells had intense chromatin 
structure at the periphery of nucleus (white arrows) and had 
cytoplasm rich in vacuoles (black arrows).
mRNA expression and DNA methylation of SF-1 
in rat placentae
To explore whether the changed DNA methylation 
of SF-1 also occurred in placentae, we determined 
the DNA methylation and mRNA expression of SF-1 
in rat placentae. The reverse-transcription PCR (RT-
PCR) analysis exhibited that SF-1 mRNA expression 
in the undernutrition placentae markedly reduced to 
65.5% of the control (P<0.05, Figure 4A). Figure 4B 
demonstrated the methylation map of CpG sites in the 
-280/+60 domain of rat SF-1. The total methylation 
rate of SF-1 promoter in the undernutrition group was 
significantly higher than that in the control (P<0.05, 
Figure 4C). More importantly, the hypermethylated SF-1 
CpG sites in rat placentae were the same as those in 
maternal blood under prenatal maternal undernutrition 
(P<0.05, Figure 4D).
Developmental parameters and mRNA 
expression of developmental genes in fushi 
tarazu factor 1b (ff1b) knockout zebrafish
The SF-1 ortholog ff1b, was knocked out in 
zebrafish by clustered regularly interspaced short 
palindromic repeats/CRISPR-associated protein 9 
(CRISPR/Cas9) technology (Supplementary Figure 2). 
Developmental parameters of F3 zebrafish were measured 
to analyze the effects of ff1b on zebrafish development. 
There were significantly decreased body lengths 
(P<0.05, Figure 5A) and increased IUGR rates (P<0.05, 
Figure 5B) in mutant-type (MT) embryos at 6 days post-
fertilization (dpf) in comparison to the wild-type (WT) 
embryos. Different from the WT group (Figure 5C, 5E), 
the 6-dpf MT embryos demonstrated delayed yolk sac 
absorption, accompanying with yolk sac edema and 
smaller fish bladders (Figure 5D, 5F). The body segment 
numbers (Figure 5G) and general morphology score 
(GMS) (Figure 5H) showed no significant changes at the 
observed time points. To evaluate the delayed embryonic 
development at the organogenic level, the expression 
of goosecoid (gsc) and krx-20 were determined in F3 
zebrafish embryos at 12 hour post-fertilization (hpf). 
Both mRNA levels of gsc (P<0.05, Figure 5I) and krx-
20 (P<0.05, Figure 5J) significantly decreased in F3 MT 
zebrafish embryos compared to the WT group.
Figure 2: DNA methylation status of steroidogenic factor 1 (SF-1) in maternal rat blood under prenatal maternal 
undernutrition. CpG methylation status in the -280/+60 domain of rat SF-1 was detected by the bisulfite sequencing PCR (BSP) 
method. +1 is the transcription start site. (A) The methylation map. Black and white circles represent methylated and unmethylated CpGs, 
respectively. (B) The total methylation rate of CpG sites; (C) the CpG sites with changed methylation frequency. *P<0.05, Fisher’s exact 
test, n = 3 pregnant rats.
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DNA methylation of SF-1 promoter in human 
maternal blood
Further, we collected human maternal blood to 
confirm the DNA methylation status of SF-1 promoter in 
normal and IUGR pregnancies. The clinical characteristics 
of pregnant women were presented in Table 3. There were 
no intergroup differences in maternal age, gestational age 
(GA) at delivery and body mass index (BMI). The birth 
weight was significantly lower in IUGR groups compared 
with the control group (P<0.05). The methylation status of 
CpG sites within the -483/-28 domain of SF-1 in maternal 
blood, which covers the binding sites for transcription 
factors, was detected by bisulfite sequencing PCR (BSP) 
analysis. Figure 6A exhibited the methylation map of 
CpG rich region in the two groups. The increased total 
methylation rates of SF-1 promoter were observed 
in IUGR pregnant women (P<0.05, Figure 6B). Few 
differences at each single CpG site were shown between 
the two groups.
DISCUSSION
DNA methylation patterns in maternal blood 
may reflect increased placental apoptosis in 
IUGR
Prenatal maternal undernutrition is the most 
common method to establish IUGR models with a high 
IUGR rate. Based on our previous studies [27], the IUGR 
rat model was successfully established via a restricted 
diet from the early to the middle gestation. According 
to the results of genomic DNA sequencing, maternal 
blood of the undernutrition group demonstrated changed 
DNA methylation status of genes related to transcription, 
apoptosis, cardiac development, neurodevelopment and 
placental development. These results were in line with 
our previous studies on nicotine-induced IUGR [28]. 
Similar results were also found in placentae with early-
onset pre-eclampsia by Blair et al [8]. Cardiovascular 
system and nervous system are two vital systems for fetal 
Figure 3: Histological changes and cell apoptosis in rat placentae under prenatal maternal undernutrition. Paraffin 
sections stained with hematoxylin and eosin (HE) were observed under a light microscope. (A) Control (40×, 200×); (B) undernutrition 
(40×, 200×). Syncytiotrophoblast apoptosis in the labyrinth zone was detected by TdT-mediated dUTP nick end labeling (TUNEL). (C) 
Control (200×); (D) undernutrition (200×). Black arrow: syncytiotrophablast. The submicroscopic structure of syncytiotrophoblast was 
analyzed by transmission electron microscope (TEM). (E) Control (2000×); (F) undernutrition (2000×). White arrow: nucleus. Black 
arrow: vacuoles. (G) Semi-quantitative analysis of TUNEL. Mean ± SD, *P<0.05, two-sided t-test, n = 3 pregnant rats.
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development. It has been reported that symmetric IUGR 
is associated with the development of cardiovascular 
disease, coronary heart disease and a relatively larger brain 
[29, 30]. Damaged placental development and increased 
apoptosis can inhibit the fetal development through 
inducing an adverse intrauterine environment [6, 14, 31]. 
Therefore, we proposed that the above-mentioned DNA 
methylation changes in maternal blood may reflect the 
occurrence of IUGR.
Among these changed functional clusters, increased 
placental apoptosis has been reported to be a possible 
mechanism for placental dysfunction and the occurrence 
of IUGR [25, 26]. Meanwhile, excessive placental 
trophoblast apoptosis has been reported to be reflected by 
extracellular DNA hypermethylation in maternal plasma 
[32]. Our previous study has demonstrated that caffeine 
treatment in rats may induce IUGR by increasing p53-
dependent placental apoptosis [31]. In our present study, 
placentae were sampled on GD14, when the placenta is 
definitively formed [33]. Besides the relatively lower 
placental weights, the histological damages were 
observed in HE-staining IUGR placentae. Furthermore, 
the increased numbers of apoptotic cells was observed in 
the IUGR placentae using TUNEL and TEM detection. 
Thus, we speculated that increased placental apoptosis in 
IUGR may be reflected by the DNA methylation patterns 
in maternal blood.
Hypermethylated SF-1 in maternal blood could 
reflect its hypermethylation and increased 
apoptosis in IUGR placentae
In this high-throughput sequencing, genes regulating 
transcription demonstrated the most significantly changed 
DNA methylation status. And the 4 DMR-associated 
transcription factors about placenta are crucial for 
maintaining placental function. Caudal type homeo 
box 2 (CDX2) enhances trophoblast cell invasion by 
altering the expression of matrix metalloproteinases [34]. 
Cryptochrome circadian clock 2 (CRY2) regulates the 
normal placental phenotype by affecting physiological 
rhythms [35]. Retinoic acid receptor alpha (RARA) 
Figure 4: mRNA expression and DNA methylation of steroidogenic factor 1 (SF-1) in rat placenta under prenatal 
maternal undernutrition. (A) Real-time quantitative PCR was used to detect the mRNA expression. Mean ± SD, *P<0.05, two-sided 
t-test, n = 6 control vs. 5 undernutrition pregnant rats. CpG methylation status in the -280/+60 domain of rat SF-1 was detected by the 
bisulfite sequencing PCR (BSP) method. +1 is the transcription start site. (B) The methylation map. Black and white circles represent 
methylated and unmethylated CpGs, respectively. (C) The total methylation rate of CpG sites; (D) the CpG sites with changed methylation 
frequency. *P<0.05, **P<0.01, Fisher’s exact test, n = 3 pregnant rats.
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regulates placental steroidogenesis by mediating 
mRNA expression and enzymatic activity of 17-beta 
hydroxysteroid dehydrogenase type 2 (HSD17B2) [36]. 
SF-1 plays an important role in placental morphogenesis. 
Aberrant DNA methylation and expression of SF-1 can 
lead to placental apoptosis and IUGR [21, 37]. Meanwhile, 
SF-1 methylation has been explored in the development 
of endocrine organs [38]. Inhibited SF-1 expression 
was observed on GD20 in fetal adrenals of IUGR rats 
induced by different prenatal exposures [20, 39]. Huang 
et al. [40] also observed inhibited SF-1 expression in 
adrenals of adult IUGR rats. In addition, we exposed 
zebrafish embryos to different IUGR risk factors (caffeine 
and nicotine) and observed lower ff1b expression and 
lower body length since 48hpf (Supplementary Figure 
1). These reports imply that IUGR occurrence may be 
accompanied by persistently inhibited SF-1 expression. 
As to maternal blood, notably hypermethylated SF-1 was 
Figure 5: Developmental parameters and mRNA expression of developmental genes in fushi tarazu factor 1b (ff1b) 
knockout zebrafish by CRISPR/Cas9 technology. (A-D) Developmental parameters of F3 zebrafish embryos; (A) body lengths; 
(B) intrauterine growth retardation (IUGR) rates; (C) the whole body of F3 wild-type (WT) embryos at 6 days post-fertilization (dpf); (D) 
the whole body of F3 mutant-type (MT) embryos at 6 dpf; (E) the yolk and swim bladder of F3 WT embryos at 6 dpf; (F) the yolk and swim 
bladder of F3 MT embryos at 6 dpf. White arrow: swim bladder; black arrow: yolk. (G) Segment number; (H) general morphology score 
(GMS). Mean ± SD, *P<0.05, two-sided t-test, n = 3 F2 zebrafish. Real-time reverse-transcription PCR (RT-PCR) was used to detect the 
mRNA expression of developmental genes in F3 embryos. (I) goosecoid (gsc) expression in F3 embryos at 12 hours post-fertilization (hpf); 
(J) krox20 expression in F3 embryos at 12 hpf. Mean ± SD, *P<0.05, two-sided t-test, n = 3 embryos.
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observed in our previous prenatal nicotine-induced IUGR 
rats [28]. Combing our and others’ results, we chose SF-1 
DNA methylation for further verification as a potential 
biomarker for IUGR in maternal blood.
The DNA methylation pattern of peripheral 
blood, which can reflect the global DNA methylation 
patterns, has been reported to predict the changed DNA 
methylation pattern occurring in the specific tissue [41]. 
In this study, BSP analysis confirmed the increased SF-1 
methylation in both maternal blood and placentae of the 
undernutrition group. More importantly, the significantly 
changed 5 CpG sites in maternal blood were the same as 
those in the placentae. Thus, DNA methylation status of 
SF-1 in maternal blood could reflect that in the placenta. 
Decreased SF-1 mRNA expression was also observed 
in placentae of IUGR, which was in line with the effects 
of hypermethylated SF-1 on the corresponding mRNA 
expression. SF-1 was reported to affect placental apoptosis 
by regulating the expression of pro-apoptotic genes [19, 21, 
37]. Meanwhile, increased placental apoptosis was reported 
to be reflected in the maternal blood. For example, apoptotic 
trophoblast cells may release IUGR-related mRNA into the 
maternal blood, which could be determined to predict IUGR 
[5, 6]. By culturing the primary trophoblastic cells, Tjoa et 
al. [23] observed the relationship between the increased 
cell-free DNA in the supernatant and the increased cell 
apoptosis. Thus, we speculated that hypermethylated SF-1, 
which can inhibit SF-1 expression and increase placental 
apoptosis, may be reflected in maternal blood and as a 
potential IUGR biomarker.
Hypermethylated SF-1 in maternal blood could 
be a potential IUGR biomarker
Further we aimed to verify the role of DNA 
methylation of SF-1 in fetal development. At present, the 
modification of DNA methylation in the specific region 
of a single gene has not been conducted successfully 
in vivo. But it is well-known that DNA hypermethylation 
decreases gene expression at the level of transcription. 
Therefore, we knocked out maternal SF-1 expression 
to represent DNA hypermethylation status of SF-1, 
and investigated the effects of knock-out SF-1 on the 
embryonic development to verify the relationship between 
Table 3: Clinical characteristics of pregnant women
Characteristic Controls (n=4) IUGR (n=4)
Maternal age (y) 31.7 ± 3.2 32.2 ± 3.5
BMI (kg/m2) 19.8 ± 2.9 22.1 ± 3.0
Primigravida (n) 4 4
GA at delivery (wk) 39.3 ± 1.1 38.9 ± 1.8
Birth weight (kg) 3.4 ± 0.4 2.1 ± 0.3*
Data were evaluated with two-sided t-test, and were given as mean ± SD and number. *P<0.05 vs control. BMI, body mass 
index; GA, gestational age; IUGR, intrauterine growth restriction.
Figure 6: DNA methylation status of steroidogenic factor 1 (SF-1) in human maternal blood of normal pregnancies 
and pregnancies with intrauterine growth retardation (IUGR). CpG methylation status in the -483/-28 domain of human SF-1 
was detected by the bisulfite sequencing PCR (BSP) method. +1 is the transcription start site. (A) The methylation map. Black and white 
circles represent methylated and unmethylated CpGs, respectively. (B) The total methylation rate of CpG sites. *P<0.05, Fisher’s exact test, 
n = 4 pregnant women.
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increased DNA methylation of SF-1 and IUGR. Due to 
the shorter experimental period and the higher mutation 
rate, ff1b (the SF-1 ortholog in zebrafish) was knocked 
out in zebrafish by CRISPR/Cas9 technology. The mutant 
zebrafish were bred for three generations to minimize the 
off-target effects of the genome editing.
In this study, we successfully developed hereditable 
ff1b knockout MT zebrafish, which can be reflected by 
the decreased ff1b mRNA expression in F2 MT zebrafish 
(Supplementary Figure 2). The mutant homozygotes in our 
study can only survive up to 15 dpf, which is in line with the 
report by Chai et al [42]. Thus, mutant heterozygotes were 
used for the subsequent experiments. The results showed 
that the F3 MT embryos had inhibited developmental 
parameters and increased IUGR rates at 6 dpf, which is 
equivalent to GD18.5 in mice [43]. At the genetic level, 
we also observed the significantly reduced expression of 
two ozganogenetic biomarkers (gsc and krx-20) in 12-hpf 
MT embryos [44, 45]. Thus, the knockout of maternal 
SF-1 could inhibit the expression of developmental genes 
since the early prenatal phase when the phenotypes are 
still inconspicuous. The delayed phenotypic changes may 
be resulted from the use of heterozygotes. These results 
demonstrated that decreased SF-1 expression can cause 
developmental inhibition and IUGR.
Furthermore, we compared the DNA methylation 
status of SF-1 promoter in human maternal blood between 
normal pregnancy and pregnancy with IUGR. In order to 
reduce sampling deviation, age, BMI and gestational age 
were kept consistent between the two groups. Although 
no single CpG sites of the SF-1 promoter showed 
significantly different DNA methylation rates between 
the two groups, the total methylation frequency of SF-1 
promoter in the IUGR group was much higher than that of 
the control. These results implied the possibility of SF-1 
hypermethylation in maternal blood as a potential IUGR 
Figure 7: The experimental scheme for CRISPR/Cas9 targeted fushi tarazu factor 1b (ff1b) mutation in zebrafish. hpf: 
hour post-fertilization; MT: mutant-type; RT-PCR: reverse-transcription PCR; T7EI: T7 endonuclease I; WT: wild-type.
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biomarker in clinic, despite the relatively low number of 
pregnant women in this study.
MATERIALS AND METHODS
Chemicals and reagents
Isoflurane was obtained from Baxter Healthcare Co. 
(Deerfield, IL, USA). The TUNEL kit was from Promega 
Co. (Madison, WI, USA). The genomic DNA preparation 
kit was purchased from Vitagene Co. (Hangzhou, China). 
The pGEM-T Easy vector was from Promega Co. 
(Madison, WI, USA). T7 endonuclease I (T7EI), pXT 
7 vector and pMD 19-T vector were purchased from 
New England Biolabs Inc. (Beverly, MA, USA). The 
mMESSAGE mMACHINE kit was from Ambion (Austin, 
TX, USA). The TIANgel Midi purification kit was 
obtained from Tiangen Biotech Co., Ltd. (Beijing, China). 
The EZ DNA methylation kit was provided by Zymo 
Research Co. (Orange, CA, USA). All other chemicals and 
reagents were of analytical grade.
Experiments in rats
Animals and treatments
Specific pathogen-free Wistar rats, females 
weighing 200 ± 20 g and males weighing 280 ± 20 g 
were from the Experimental Center of the Hubei Medical 
Scientific Academy (No. 2008-0005, Hubei, China). The 
rat experiments were performed in the Center for Animal 
Experimentation of Wuhan University (Wuhan, Hubei, 
China), which has been accredited by the Association for 
Assessment and Accreditation of Laboratory Animal Care 
(AAALAC) International.
Two female rats were mated with one male rat 
overnight after 7 days of acclimation. The day to observe 
vaginal smear with sperm cells was designated as GD0. 
Rats in the control group were allowed free access to 
standard chow and water, while rats in the undernutrition 
group were put on a restricted diet (50% food intake of the 
GD-matched control rats) from GD0. On GD14, pregnant 
rats were anesthetized with isoflurane and euthanized by 
decapitation. Maternal blood was collected in sodium 
citrate tubes. Fetuses and placentae were weighed after 
being dried on filter paper. IUGR was diagnosed when 
a fetal weight was two standard deviations lower than 
the mean body weight of control group [46]. IUGR rates 
were calculated by dividing the number of IUGR in each 
litter by the total pups of the litter. Three placentae in each 
group were randomly selected for fixing in 10% neutral 
formalin solution to make paraffin slices. Another three 
placentae in each group were randomly selected and 
immersed in 3% glutaraldehyde/1.5% paraformaldehyde 
solution for TEM analysis. The remaining placentae were 
stored at -80°C.
Histopathological measurement of placentae
For light microscopy analysis, 5 μm-thick paraffin 
sections were stained with HE and TUNEL, respectively. 
For TEM analysis, samples were postfixed for 1.5 h in 1% 
osmium tetroxide/1.5% potassium ferrocyanide solution, 
dehydrated in graded concentrations of ethanol, and 
embedded in Epon 618. Ultrathin sections approximately 
70 nm thick were stained with uranyl acetate and lead 
citrate, and examined using a Hitachi H600 TEM (Hitachi, 
Co., Tokyo, Japan).
High-throughput bisulfite sequencing in maternal 
blood
Genomic DNA was isolated from 3 samples of 
maternal blood using the genomic DNA preparation kit. 
5 ng of genomic DNA was fragmented into 400-600 nt 
using M220 Focused-ultrasonicator from Covaris Inc. 
(Woburn, MA, USA), followed by bisulfite conversion 
with the EZ DNA methylation kit. Bisulfite-converted 
DNA was used for illumina pair-end library preparation 
with the EpiGonme Methyl-seq kit. The libraries were 
applied to illumine Nextseq 500 system for 150 nt pair-
end high-throughput sequencing by ABlife Inc. (Wuhan, 
Hubei, China). DMRs were identified based on the DNA 
methylation status of every sample. Among the top 3000 
DMR associated genes, functional clustering analysis was 
employed to screen out the functional clusters and genes 
needing subsequent confirmation.
BSP analysis in maternal blood and placentae
The methylation status of CpG sites in the -280/+60 
domain of SF-1 proximal promoter was determined by 
BSP analysis. The DNA sequence of this domain was 
referred to UCSC Genome Browser (http://genome.ucsc.
edu/) and demonstrated in Supplementary Database 1. 
10 clones were sequenced for each sample. The detailed 
protocols were published in our previous study [20].
Real-time RT-PCR analysis in placentae
Placental SF-1 mRNA expression was determined 
by real-time RT-PCR. Detailed protocols were published 
in our previous study [20].
Experiments in zebrafish
Maintenance of zebrafish
WT AB strain zebrafish were supplied by the Key 
Laboratory of Biodiversity and Conservation of Aquatic 
Organism, Institute of Hydrobiology, Chinese Academy of 
Sciences (Wuhan, Hubei, China). Zebrafish were raised at 
28 ± 0.5 °C in a 14:10 h light: dark cycle in a closed flow-
through system. Zebrafish embryos were obtained from 
spawning adults in groups of 20 males and 10 females in 
tanks overnight. Spawning was induced in the morning 
when the light was turned on. Normally developed 
embryos were selected at 4-5 hpf.
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CRISPR/Cas9 targeted mutation technology
ff1b, the SF-1 ortholog, was knocked out in 
zebrafish through CRISPR/Cas9 targeted mutation [47]. 
The experimental scheme was shown in Figure 7. The full-
length Cas9 cDNA was cloned into the pXT 7 vector. The 
capped Cas9 mRNA was produced using the  mMESSAGE 
mMACHINE kit. The corresponding ff1b gRNA sequence 
was cloned into the pMD 19-T vector, the primers of 
which (forward: 5'-GCGATGCTACATTCAGTGTC-3'; 
reverse: 5'-CCGTCAAATAAGATAACAGGG-3') were 
designed at http://zifit.partners.org/ZiFiT/. The gRNA 
sequence was amplified into double-stranded DNA by 
PCR. And the corresponding primers were as follows: 
forward: 5'-TGTAATACGACTCACTATAGAGGAGCT
TTGCCCGGTGTGGTTTTAGAGCTAGA-3'; reverse: 
5'-AGCACCGACTCGGTGCCACT-3'. The products were 
identified by agarose gel electrophoresis and purified by 
the TIANgel Midi purification kit.
One-cell stage zebrafish embryos were injected 
with 8 nL solution containing 20 ng/μL gRNA and 300 
ng/μL Cas9 mRNA. Genomic DNA was isolated from 
these injected embryos at 48 hpf and was digested in 5 
μg/mL proteinase K for 90 min at 65°C, followed by 15 
min at 95°C. The genomic targeted region was amplified 
by PCR. Primers (annealing 58°C, 30 s) were as follows: 
forward: 5'-GAGCTTTCAGAGAACATTTAGAA-3'; 
reverse: 5'-CAGCACACCACAGTTTACTGTAG-3'. The 
PCR amplicon was then denatured slowly and reannealed 
to facilitate the heteroduplex formation. The product 
was digested with 5 units of T7EI at 37°C for 90 min. 
Then the digested samples were analyzed by agarose gel 
electrophoresis. For further confirmation, the purified 
PCR products were cloned into the pGEM-T easy vector 
and analyzed by Sanger sequencing.
The screen-out MT zebrafish, which were taken as 
the F0 zebrafish, were backcrossed with the WT zebrafish 
at postnatal week 12. At 12 hpf, dead or deformed F1 
embryos were removed. The tail fins of F1 zebrafish were 
collected at postnatal week 12 and analyzed as described 
above to search for MT zebrafish. F1 MT zebrafish were 
backcrossed with the WT zebrafish at postnatal week 
12. F2 MT zebrafish were screened out according to the 
screening methods in F1 zebrafish.
Development of F3 embryos
At postnatal week 12, F2 MT zebrafish were 
backcrossed with the WT zebrafish. At 12 hpf, dead or 
deformed F3 embryos were removed. The body length, 
yolk sac absorption and IUGR rate were recorded at 
24 hpf, 36 hpf, 48 hpf, 72 hpf, 4dpf, 5 dpf and 6 dpf, 
respectively. The embryo was taken as IUGR when its 
body length was 10% shorter than the mean body length 
of the control group [46]. The body segment number 
was recorded at 24 hpf and 48 hpf. And embryonic 
development was scored at 24 hpf, 48 hpf and 72 hpf, 
following the GMS [48].
Real-time RT-PCR analysis
Real-time RT-PCR was used to detect ff1b mRNA 
expression in F2 zebrafish at postnatal week 12, and the 
mRNA expression of gsc and krx-20 in 12-hpf F3 embryos. 
Total RNA was isolated from the tail fins of F2 zebrafish and 
F3 embryos as described in RT-PCR analysis in placentae. 
Each sample was normalized on the basis of β-actin mRNA 
content. Primers and annealing conditions were shown in 
Supplementary Table 1.
SF-1 methylation analysis in peripheral blood of 
pregnant women with IUGR
Participants
In this study, all subjects were recruited between 
February 2014 and May 2015 from routine prenatal 
screening in the Department of Obstetrics and Gynecology 
at Enshi General Hospital, Hubei, China. Eight Han 
Chinese primiparae were selected (at 28-32 gestational 
weeks) for normal or IUGR singleton pregnancies. IUGR 
was diagnosed when fetal abdominal circumference 
and/or estimated fetal weight were below the tenth 
percentile for GA, with a reduction of growth on repeated 
ultrasonographic evaluation and abnormal umbilical artery 
blood flow waveform on Doppler examination. None of 
the participants had histories of preexisting hypertension, 
diabetes mellitus, liver disease, or chronic kidney disease.
Peripheral blood sampling and DNA isolation
Maternal peripheral blood samples were taken by 
venipuncture. 3 mL of maternal blood was collected into 
an EDTA tube. Genomic DNA in maternal blood was 
extracted by the genomic DNA preparation kit and stored 
at -20°C for BSP analysis.
BSP analysis
The methylation status of CpG sites in the -483/-
28 domain of SF-1 proximal promoter was determined 
by BSP analysis. The DNA sequence of this domain was 
referred to UCSC Genome Browser (http://genome.ucsc.
edu/) and demonstrated in Supplementary Database 1. 5 
clones were sequenced for each sample. Two primers were 
used for PCR amplification (SF1-1 and SF1-2), which 
cover the CpG rich region of proximal SF-1 promoter. 
Primers of SF1-1 (-483 nt ~ -190 nt) were as follows: 
forward: 5’-AAAAGAGGTGGAAGTAGTAGGT-3’; 
reverse: 5’-CCTTAACCAACTAA CTATTCCA-3’. 
Primers of SF1-2 (-321 nt ~ -28 nt) were as follows: 
forward: 5’-GGGTGGGGGAGTAGTTTATAAA-3’; 
reverse: 5’-CCAATTAATCTCTACCCCCAC-3’. 
The amplification conditions were as follows: initial 
denaturation at 98°C for 2 min; 45 cycles of denaturation 
at 95°C for 30 s, anneal at 60°C for 30 s, and extension at 
72°C for 30 s; a final elongation step at 72°C for 10 min.
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Ethics statement
All procedures performed in studies involving 
animals were in accordance with the Guidelines for 
Animal Research, and were approved by the Ethical 
and Research Committee of Medical College of Wuhan 
University (No. 00092764). All procedures performed in 
studies involving human participants were in accordance 
with the ethical standards of the institutional and/or 
national research committee and with the 1964 Helsinki 
declaration and its later amendments or comparable ethical 
standards. The human subject research was approved by 
the Ethical and Research Committee of Wuhan University 
(No. 12016), China. The written informed consents were 
obtained from all participants included in the study.
Statistical analysis
SPSS 15.0 from SPSS Science Inc. (Chicago, IL, USA) 
and Graphpad Prism 5.0 from GraphPad Software (La Jolla, 
CA, USA) were used for data analysis. All measurement 
data were expressed as the mean ± SD and evaluated with 
two-sided t-test. Enumeration data, such as IUGR rates were 
firstly calculated and then arcsine square-root transformed 
to make the data following normal distribution [49]. The 
methylation frequencies were evaluated by Fisher’s exact 
test. Statistical significance was set at P<0.05.
CONCLUSIONS
In summary, distinct DNA methylation profile exists 
in maternal blood of IUGR rats. SF-1 plays an important 
role in fetal development and the occurrence of IUGR. 
Hypermethylated SF-1 in the maternal rat blood could be 
a potential IUGR biomarker. The underlying mechanism 
may be as follows: hypermethylated SF-1 inhibited its 
gene expression in the placenta, which could lead to 
increased placental apoptosis and IUGR. As apoptotic cells 
flows into maternal blood, the changed DNA methylation 
patterns in apoptotic placentae can be reflected in maternal 
blood. To our knowledge, we firstly used genomic DNA 
methylation sequencing to screen out potential IUGR 
biomarkers in maternal blood from the perspective of 
DNA methylation. It will provide evidence for IUGR 
pathophysiology and non-invasive prenatal prediction 
of IUGR. Further analysis for SF-1 hypermethylation 
in more types of tissues on a larger scale will be needed 
to confirm the role of hypermethylated SF-1 in prenatal 
IUGR diagnosis.
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